Subscribe To
ALXO / ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference
ALXO News
By Seeking Alpha
October 9, 2023
ALX Oncology: On Right Track With Latest Interim Analysis Of Evorpacept
ALX Oncology reported positive interim results from its phase 2 study using its anti-CD47 drug for HER2-positive gastric/gastroesophageal junction can more_horizontal
By Proactive Investors
October 3, 2023
ALX Oncology stock doubles on early data from phase II cancer trial
ALX Oncology Holdings Inc saw its stock value double in pre-market trading on the heels of promising interim data from a phase II study assessing th more_horizontal
By Zacks Investment Research
August 10, 2023
ALX Oncology Holdings Inc. (ALXO) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?
ALX Oncology Holdings Inc. (ALXO) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled more_horizontal
By GlobeNewsWire
January 3, 2023
ALX Oncology to Present at the 41st Annual J.P. Morgan Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO), a clinical-stage immun more_horizontal